Catalyst Wire Dossier Catalyst Wire Dossier

Replexa+ Shortwave Diathermy Device

· Indiana University
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Replexa+ Shortwave Diathermy Device, covering 2026-01-15 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy [NA]

See pricing